Intervention: 1 dose of Meningococcal (group B) multicomponent recombinant adsorbed vaccine
Found 6 matching trials
Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants
PHASE1
Primary Objective:
* To describe the safety profile of the SP MenB vaccine...
Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of Booster Doses of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received One or Four Doses of the Same Vaccine
PHASE2
The proposed study V72P6E1 is an Extension Study of V72P6 (NCT00381615). Th...
Status
Completed
Location
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital
Persistence of Antibody Levels and Response to Fifth or Third Meningococcal B Recombinant Vaccine in 4-year Old Healthy Children Who Previously Participated in Study V72P12E1
PHASE3
It is a Phase 3 extension of study V72P12E1 (NCT00944034). The main aim of ...
Safety, Tolerability and Immunogenicity of a Third Dose of One of Four Different Formulations of rMenB + MenACWY Combination Vaccine in Adolescents Who Previously Received the Same Study Vaccines
PHASE2
This study will evaluate safety, tolerability, and immunogenicity of a boos...